Senomyx, Inc. (NASDAQ: SNMX) Investor Investigation Over Possible Wrongdoing In Acquisition Announced

Investors who purchased shares of Senomyx, Inc. (NASDAQ: SNMX) and currently hold any of those NASDAQ: SNMX shares have certain options and should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Senomyx
Affected Securities: 
NASDAQ: SNMX

An investigation on behalf of investors, who currently hold shares of Senomyx, Inc. (NASDAQ: SNMX), was announced concerning whether the takeover of Senomyx, Inc. by Firmenichis unfair to NASDAQ: SNMX stockholders.

The investigation by a law firm concerns whether certain officers and directors of Senomyx, Inc. breached their fiduciary duties owed to NASDAQ: SNMX investors in connection with the proposed acquisition.
San Diego, CA based Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States.

On September 17, 2018, Firmenich and Senomyx, Inc. (NASDAQ: SNMX) announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per share in cash.

However, given that shares of Senomyx, Inc. (NASDAQ: SNMX) reached in December 2017 as high as $1.67 per share, the investigation concerns whether the offer is unfair to NASDAQ: SNMX stockholders. More specifically, the investigation concerns whether the Senomyx Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Senomyx, Inc. (NASDAQ: SNMX) reported that its annual Total Revenue rose from $23.03 million in 2016 to $29.32 million in 2017 and that its Net Loss declined from $10.68 million in 2016 to $1.26 million in 2017.

Shares of Senomyx, Inc. (NASDAQ: SNMX) closed on September 27, 2018, $1.48 per share.